PL2491117T3 - Udoskonalone sposoby odzyskiwania wirusa wykorzystujące odwrotną genetykę - Google Patents

Udoskonalone sposoby odzyskiwania wirusa wykorzystujące odwrotną genetykę

Info

Publication number
PL2491117T3
PL2491117T3 PL10773996T PL10773996T PL2491117T3 PL 2491117 T3 PL2491117 T3 PL 2491117T3 PL 10773996 T PL10773996 T PL 10773996T PL 10773996 T PL10773996 T PL 10773996T PL 2491117 T3 PL2491117 T3 PL 2491117T3
Authority
PL
Poland
Prior art keywords
reverse genetics
improved reverse
virus rescue
genetics methods
methods
Prior art date
Application number
PL10773996T
Other languages
English (en)
Inventor
Philip Dormitzer
Björn Keiner
Pirada Suphaphiphat
Michael Franti
Peter Mason
Jennifer Uhlendorff
Mikhail Matrosovich
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43382472&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2491117(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PL2491117T3 publication Critical patent/PL2491117T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
PL10773996T 2009-10-20 2010-10-20 Udoskonalone sposoby odzyskiwania wirusa wykorzystujące odwrotną genetykę PL2491117T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27948709P 2009-10-20 2009-10-20
EP10773996.3A EP2491117B2 (en) 2009-10-20 2010-10-20 Improved reverse genetics methods for virus rescue
PCT/IB2010/054752 WO2011048560A1 (en) 2009-10-20 2010-10-20 Improved reverse genetics methods for virus rescue

Publications (1)

Publication Number Publication Date
PL2491117T3 true PL2491117T3 (pl) 2014-05-30

Family

ID=43382472

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10773996T PL2491117T3 (pl) 2009-10-20 2010-10-20 Udoskonalone sposoby odzyskiwania wirusa wykorzystujące odwrotną genetykę

Country Status (13)

Country Link
US (2) US8883481B2 (pl)
EP (1) EP2491117B2 (pl)
JP (2) JP5871806B2 (pl)
KR (1) KR20120083480A (pl)
CN (1) CN102741399A (pl)
AU (2) AU2010309404B2 (pl)
CA (1) CA2778332A1 (pl)
EA (1) EA023811B1 (pl)
ES (1) ES2454815T3 (pl)
NZ (1) NZ599479A (pl)
PL (1) PL2491117T3 (pl)
SI (1) SI2491117T1 (pl)
WO (1) WO2011048560A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201507454XA (en) 2013-03-13 2015-10-29 Novartis Ag Influenza b virus reassortment
CN105722976A (zh) 2013-06-06 2016-06-29 诺华股份有限公司 流感病毒重配
EP4299766A3 (en) 2016-09-27 2024-05-01 Osaka University Method for preparing artificial recombinant rotavirus
ES2991988T3 (es) 2017-10-30 2024-12-05 Takeda Pharmaceuticals Co Detergentes compatibles con el medio ambiente para la inactivación de virus con envoltura lipídica
CN110029129A (zh) * 2019-03-06 2019-07-19 华南农业大学 一种表达鸡st3gal 1基因的mdck稳转细胞株的构建方法
CN110042084A (zh) * 2019-04-11 2019-07-23 浙江森卫生物医药发展有限公司 一种活病毒流感疫苗的生产方法以及制剂
CN117625688B (zh) * 2024-01-26 2024-04-30 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） B亚型禽偏肺病毒反向遗传操作系统及其应用

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2017507C (en) 1989-05-25 1996-11-12 Gary Van Nest Adjuvant formulation comprising a submicron oil droplet emulsion
WO1995011700A1 (en) 1993-10-29 1995-05-04 Pharmos Corp. Submicron emulsions as vaccine adjuvants
ATE181112T1 (de) 1995-08-09 1999-06-15 Schweiz Serum & Impfinst Dem genom von minussträngigen rna-viren entsprechende cdna und verfahren zur herstellung von infektiösen minussträngigen rna-viren
DE19612966B4 (de) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
DE19612967A1 (de) 1996-04-01 1997-10-02 Behringwerke Ag Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren
TW570803B (en) 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
US6080725A (en) 1997-05-20 2000-06-27 Galenica Pharmaceuticals, Inc. Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
KR100619319B1 (ko) * 1998-06-03 2006-09-06 와이어쓰 홀딩스 코포레이션 리보핵산 바이러스의 신규 구제방법
GB9916794D0 (en) * 1999-07-16 1999-09-22 Isis Innovation In vitro virus reconstitution
PL355287A1 (pl) 1999-09-24 2004-04-05 Smithkline Beecham Biologicals S.A. Donosowa szczepionka przeciw wirusowi grypy
KR100797547B1 (ko) 2000-03-03 2008-01-24 자이단호진 가가쿠오요비겟세이료호겐쿠쇼 무혈청 배양 및 부유 배양에서 사용할 수 있는 세포 및상기 세포를 사용하여 백신용 바이러스를 제조하는 방법
ES2319864T3 (es) * 2000-04-28 2009-05-14 St. Jude Children's Research Hospital Sistema de transfeccion de adn para la generacion de virus infecciosos de arn de cadena negativa.
CA2412621A1 (en) † 2000-06-23 2002-01-03 American Cyanamid Company Rescue of canine distemper virus from cdna
GB0024089D0 (en) 2000-10-02 2000-11-15 Smithkline Beecham Biolog Novel compounds
EP2281573A3 (en) 2001-02-23 2011-12-07 GlaxoSmithKline Biologicals s.a. Influenza vaccine formulations for intradermal delivery
CA2438960A1 (en) 2001-02-23 2002-09-06 Glaxosmithkline Biologicals S.A. Influenza vaccine formulations for intradermal delivery
MY134424A (en) 2001-05-30 2007-12-31 Saechsisches Serumwerk Stable influenza virus preparations with low or no amount of thiomersal
DE10144903A1 (de) * 2001-09-12 2003-03-27 Chiron Behring Gmbh & Co Vermehrung von Viren in Zellkultur
DK1499348T3 (en) * 2002-04-26 2015-01-05 Medimmune Llc PROCEDURE FOR PREPARING INFECTIOUS INFLUENZA B-VIRA IN CELL CULTURE
EP1633860A2 (en) † 2003-06-09 2006-03-15 Wyeth IMPROVED METHOD FOR THE RECOVERY OF NON-SEGMENTED, NEGATIVE-STRANDED RNA VIRUSES FROM cDNA
CA2551489C (en) 2003-12-23 2013-09-03 Gregory Duke Multi plasmid system for the production of influenza virus
KR20110132416A (ko) 2004-04-05 2011-12-07 화이자 프로덕츠 인코포레이티드 미세유체화된 수중유 유화액 및 백신 조성물
WO2005113756A1 (en) 2004-05-14 2005-12-01 Glaxosmithkline Biologicals S.A. Method
JP2007537760A (ja) 2004-05-20 2007-12-27 アイディー バイオメディカル コーポレイション インフルエンザワクチンを製造するためのプロセス
DK2368975T3 (en) 2004-12-23 2015-01-05 Medimmune Llc Non-tumorigenic MDCK cell line for the propagation of viruses
US7691368B2 (en) 2005-04-15 2010-04-06 Merial Limited Vaccine formulations
US8703095B2 (en) 2005-07-07 2014-04-22 Sanofi Pasteur S.A. Immuno-adjuvant emulsion
EP1945780B1 (en) * 2005-10-14 2015-09-16 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Rabies virus vector systems and compositions and methods thereof
ES2525518T3 (es) 2005-11-01 2014-12-26 Novartis Vaccines And Diagnostics Gmbh Vacunas virales derivadas de células con niveles reducidos de ADN celular residual
JP2009514844A (ja) 2005-11-04 2009-04-09 ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル スプリットインフルエンザワクチン用のアジュバントとしての遊離水相界面活性剤を含むエマルション
FR2896162B1 (fr) 2006-01-13 2008-02-15 Sanofi Pasteur Sa Emulsion huile dans eau thermoreversible
EA015817B1 (ru) 2006-10-12 2011-12-30 Глаксосмитклайн Байолоджикалс С.А. Иммуногенная композиция, содержащая адъювант в виде эмульсии "масло в воде"
PT2121011E (pt) 2006-12-06 2014-07-31 Novartis Ag Vacinas compreendendo um antigénio a partir de quatro estirpes do vírus da gripe
EP2045323A1 (en) 2007-10-05 2009-04-08 Avir Green Hills Biotechnology Research Development Trade Ag Linear expression constructs for production of influenza virus particles
WO2010046335A1 (en) * 2008-10-21 2010-04-29 Crucell Holland B.V. Production of influenza virus by reverse genetics in per.c6 cells under serum free conditions

Also Published As

Publication number Publication date
AU2010309404B2 (en) 2015-07-09
EA023811B1 (ru) 2016-07-29
US20130034582A1 (en) 2013-02-07
EP2491117B2 (en) 2017-06-28
ES2454815T3 (es) 2014-04-11
SI2491117T1 (sl) 2014-03-31
KR20120083480A (ko) 2012-07-25
JP5871806B2 (ja) 2016-03-01
US8883481B2 (en) 2014-11-11
WO2011048560A1 (en) 2011-04-28
AU2015234265A1 (en) 2015-11-05
AU2010309404A1 (en) 2012-05-17
EP2491117B1 (en) 2014-01-01
CA2778332A1 (en) 2011-04-28
HK1175200A1 (en) 2013-06-28
JP2013507952A (ja) 2013-03-07
JP2016104004A (ja) 2016-06-09
NZ599479A (en) 2013-11-29
US20150166966A1 (en) 2015-06-18
EP2491117A1 (en) 2012-08-29
CN102741399A (zh) 2012-10-17
EA201270577A1 (ru) 2012-12-28

Similar Documents

Publication Publication Date Title
DK2457337T3 (en) Specialtilpasset impuls-burst
GB201103481D0 (en) No details
PL2453989T3 (pl) Maska oddechowa
GB201016096D0 (en) No details
EP2499034A4 (en) WHEELCHAIR
GB201016097D0 (en) No details
ZA201202823B (en) Elevator
GB0909645D0 (en) Methods
GB0906764D0 (en) Rescue aid
GB0907350D0 (en) Methods
GB201118811D0 (en) Separation alarm
GB0901001D0 (en) Methods
DK2464943T3 (en) Systemintegration
GB0912685D0 (en) Methods
PL2491117T3 (pl) Udoskonalone sposoby odzyskiwania wirusa wykorzystujące odwrotną genetykę
AU330856S (en) Safe
GB0920067D0 (en) Improved handrail
ZA201105022B (en) Fall arrest system
GB0908435D0 (en) Processes
GB0912950D0 (en) Virus
GB2469633B (en) Lifting system
GB0912159D0 (en) Methods
GB0901056D0 (en) Virus
GB2473269B (en) Emergency device-access
GB0919212D0 (en) Selective separation